EXANE DERIVATIVES - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 233 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q2 2022$1,210,000
-97.6%
39
-96.9%
0.00%
-92.9%
Q1 2022$51,117,000
-29.6%
1,245
-25.4%
0.01%
-22.2%
Q4 2021$72,592,000
-28.4%
1,670
-17.5%
0.02%
-25.0%
Q3 2021$101,338,000
-25.8%
2,024
-14.1%
0.02%
-22.6%
Q2 2021$136,514,000
-53.0%
2,357
-24.6%
0.03%
-62.7%
Q1 2021$290,424,000
-26.3%
3,126
-28.9%
0.08%
-28.4%
Q4 2020$394,132,0004,3990.12%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Zebra Capital Management LLC 25,250$784,0002.30%
Global Alpha Capital Management Ltd. 418,030$12,976,0001.40%
AIMZ Investment Advisors, LLC 70,588$2,191,0001.05%
PALISADE CAPITAL MANAGEMENT, LP 566,080$17,571,0000.48%
RICE HALL JAMES & ASSOCIATES, LLC 261,533$8,118,0000.39%
EARNEST PARTNERS LLC 1,844,621$57,257,0000.38%
SummerHaven Investment Management, LLC 14,476$449,0000.30%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,085,874$33,706,0000.26%
Ridgewood Investments LLC 10,004$311,0000.24%
DUALITY ADVISERS, LP 65,650$2,038,0000.20%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders